Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
09/08/2004 | CN1165345C Prucalopride oral solution and preparing method thereof |
09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
09/07/2004 | US6787560 Serotonin reuptake inhibitor |
09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |
09/07/2004 | US6787536 Hydroxamic acid derivatives |
09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
09/02/2004 | WO2004074438A2 Ccr8 antagonists |
09/02/2004 | WO2004074284A1 Oxazole-derivatives as ppar agonists |
09/02/2004 | WO2004074282A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
09/02/2004 | WO2004074281A1 Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs |
09/02/2004 | WO2004074280A1 Pyridine derivatives as fungicidal compounds |
09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
09/02/2004 | WO2004074272A1 Anthelmintic agents and insecticidal compositions |
09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
09/02/2004 | WO2004074244A2 Pyrimidine compounds |
09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
09/02/2004 | WO2004073629A2 Hetero substitued sodium channel blockers |
09/02/2004 | WO2004073619A2 Ccr8 antagonists |
09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
09/02/2004 | WO2004049797A3 Pesticidal sulphonylaminopyrazoles |
09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/02/2004 | US20040171860 Novel acylating reagents |
09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
09/02/2004 | US20040171838 Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom |
09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
09/02/2004 | US20040171817 Thermal printing |
09/02/2004 | US20040171798 treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
09/02/2004 | US20040171677 for combatting neuropathic pain.for the treatment of neurodegenerative diseases, preferably of Alzheimer's disease, Parkinson's disease or Huntington's chorea, migraine, stroke, cerebral ischaemia, cerebral infarct, cerebral edema, schizophrenia |
09/02/2004 | US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction |
09/02/2004 | US20040171650 Fighting parasitic infections in human and animals; 1,2,4-triazol-3-thioyl derivatives |
09/02/2004 | US20040171645 Treating extrapyramidal movement disorder adverse effects of antiparkinson's drugs |
09/02/2004 | US20040171642 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
09/02/2004 | US20040171626 having good to very good inhibitory activity against HCV polymerase; hepatitis C virus |
09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
09/02/2004 | US20040171613 Therapeutic agent for non-immediate type allergic diseases |
09/02/2004 | US20040171612 Novel compounds with analgesic effect |
09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
09/02/2004 | US20040171124 includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers; effective against human immunodeficiency virus (HIV), hepatitis B virus (HBV), and other viruses |
09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
09/02/2004 | DE20220955U1 Composition useful for treating e.g. depression, anxiety, obsessive-compulsive disorder, obesity comprises N-formyl paroxetine and a paroxetine compound |
09/02/2004 | DE10307845A1 Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclic amides, processes for their preparation, compositions containing them and their use as pesticides |
09/02/2004 | CA2516748A1 Anthelmintic agents and insecticidal compositions |
09/02/2004 | CA2516475A1 Oxazole-derivatives as ppar agonists |
09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
09/02/2004 | CA2515984A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
09/02/2004 | CA2515777A1 Biphenyl derivatives |
09/02/2004 | CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
09/01/2004 | EP1452526A1 Indole compound and medicinal use thereof |
09/01/2004 | EP1452525A1 Amide derivatives and drugs |
09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
09/01/2004 | EP1451180A1 Quinazoline compounds with therapeutic use |
09/01/2004 | EP1451179A1 Pyrrole synthesis |
09/01/2004 | EP1451178A1 Processes for preparing beta-d-ribofuranose derivatives |
09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
09/01/2004 | EP1451173A2 Piperidines |
09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
09/01/2004 | EP1451164A2 Amide derivatives having improved solubility |
09/01/2004 | EP1451160A2 Pyrazole-amides and-sulfonamides |
09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
09/01/2004 | EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
09/01/2004 | EP1450812A2 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
09/01/2004 | EP1450808A1 Quinazoline derivatives for the treatment of t cell mediated diseases |
09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
09/01/2004 | EP1242410B1 Novel compounds |
09/01/2004 | CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
09/01/2004 | CN1524852A Novel compounds with analgesic effect |
09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
09/01/2004 | CN1164587C Process for preparing Aomeishatan |
09/01/2004 | CN1164574C Phenoxypropylamine compounds |
08/31/2004 | US6784294 Reacting a pyridine- sulfanamide derivative with an amine to open the ring containing sulfur, oxygen and nitrogen atoms to form n1-(2'-pyridyl)-1,2-alkanediamine sulfamic acid, further hydrogenation and acid hydrolysis |